Albemarle Q4 2020 Earnings Report
Key Takeaways
Albemarle's Q4 2020 adjusted EBITDA exceeded expectations, driven by the hard work and diligence of the operating teams. The company is accelerating high-return growth in its Lithium and Bromine businesses while maintaining focus on operational discipline.
Net income of $84.6 million, or $0.79 per diluted share; Adjusted diluted EPS of $1.17.
Net sales of $879 million, which was at the high-end of previous outlook, a year-over-year decrease of 11%.
Adjusted EBITDA of $221 million, which exceeded the high-end of previous outlook, a year-over-year decrease of 25%.
Approximately $80 million of sustainable cost savings achieved in 2020.
Albemarle
Albemarle
Albemarle Revenue by Segment
Forward Guidance
Albemarle anticipates that its full year 2021 operating performance will improve modestly relative to full year 2020 assuming continued recovery following reduced global economic activity due to the global pandemic.
Revenue & Expenses
Visualization of income flow from segment revenue to net income